Company Overview of Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies to enhance treatment outcomes. The company’s development portfolio includes ITCA 650, an injection-free GLP-1 therapy for the treatment of Type 2 diabetes; and additional programs for weight regulation to control obesity. Intarcia Therapeutics, Inc. was formerly known as BioMedicines, Inc. and changed its name to Intarcia Therapeutics, Inc. in September 2004. The company was incorporated in 1995 and is headquartered in Hayward, California.
24650 Industrial Boulevard
Hayward, CA 94545
Founded in 1995
Key Executives for Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Novartis Consumer Health, Inc.||United States|
|Indus Pharmaceuticals, Inc.||United States|
|Axerion Therapeutics, Inc.||United States|
|Ayurcore, Inc.||United States|
|Global Clinical Trials, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Frederick, MD | Computer Sciences Corporation (CSC)Posted: Dec 16
- Billerica, MA | Mergis Group, A Division of SpherionPosted: Dec 10
- Summit, NJ | DiversantPosted: Jul 03
- Brown Deer, WI | Kelly Scientific ResourcesPosted: Dec 13
Sponsored Financial Commentaries
To contact Intarcia Therapeutics, Inc., please visit www.intarcia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.